ABSTRACT Contrast echocardiography can predict pathologic area at risk during acute coronary occlusion. In this study we evaluated (1) whether the intensity and timing of contrast appearance in ischemic regions can provide a quantitative measure of residual myocardial perfusion, and (2) whether changes in these parameters observed after serial injections reflect changes in blood flow to acutely ischemic tissue. Supra-aortic hydrogen peroxide contrast echocardiography was performed in 12 consecutive dogs at 1, 20, and 120 min after acute circumflex coronary occlusion. Contrast enhancement was determined qualitatively with a segmental four-point scoring system based on the appearance time and peak perceived intensity of contrast enhancement and quantitatively with a computer algorithm designed to reflect these parameters. Comparison was made in each segment to concomitant radioactive microsphere blood flow. Qualitative scoring related systematically to normalized segmental blood flow (3 + = 93%; 2 + = 61 %; 1 + = 32%; 0 = 18%; p < .01 for each vs adjacent value), as did quantitative analysis including all segments (r = .78; p < .01) and isolated to the ischemic region (flow = 1.13 intensity change + 6.8%; r = .83, p < .001). Changes in microsphere flow in ischemic regions between sequential observations were correlated with changes in qualitative score (r = .88, p < .001) and results of quantitative analysis (r = 0.70, p < .01). The amount of contrast enhancement can provide quantitative information about residual myocardial blood flow in ischemic regions and can also be used to track changing patterns of flow in vivo after acute coronary occlusion. Circulation 72, No. 5, 1115No. 5, -1124No. 5, , 1985 THE SUPRA-AORTIC INJECTION of microbubblecontaining solutions during echocardiographic imaging of the heart results in an intense increase in myocardial contrast in regions that receive normal blood flow. Regions that are severely malperfused do not enhance and can be seen as a contrast defect. Studies in our laboratory and others indicate that the size of this contrast defect accurately predicts the size in vivo of the region that is at risk of infarction after acute coronary occlusion.'-5 Contrast analyses have not previously been evaluated for their ability to quantify the amount, rather than the presence or absence, of flow within the ischemic region.
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During our previous studies of supra-aortic hydrogen peroxide contrast echocardiography in canine in-farction we observed in some animals a pattern of delayed contrast appearance in the initially ischemic region on observation later after an acute occlusion. In others, the pattern and amount of contrast did not change on sequential observations. The canine preparation of acute coronary ligation and infarction is notable because a substantial proportion of these animals have preformed epicardial collateral vessels that dilate in response to regional ischemia. Animals that have epicardial collaterals may show a spontaneous improvement in blood flow to the ischemic region during the first several hours after occlusion.6 7 We hypothesized that the changing pattern of the intensity of echocardiographic myocardial contrast enhancement we observed in prior experiments represented changes in regional myocardial blood flow. Therefore, the present study was designed to compare serial observations of the pattern and intensity of myocardial contrast enhancement with concomitant regional blood flow after acute coronary occlusion. Contrast enhancement resulting from supraaortic injection of hydrogen peroxide was assessed qualitatively, based on the perceived intensity and temporal course of appearance in the myocardium, and quantitatively, with a computer-based analysis of regional pixel intensity. Comparison was made with regional microsphere blood flow by use of echocardiographic markers and a grid system.
Methods
Experimental animal preparation. After preliminary imaging to ensure adequate two-dimensional echocardiographic epicardial and endocardial target definition, 12 mongrel dogs were selected for study. They were premedicated with 1 mg/kg morphine, anesthetized with 10 mg/kg pentobarbitol, intubated, and placed on a Harvard respirator. The heart was exposed through a standard left thoracotomy and the circumflex artery distal to Quantitative echocardiographic analyses were performed with a commercial computerized analysis system (Microsonics CAD 888). Single end-diastolic echocardiographic stop frames, as indicated by the initial upslope of the R wave on an accompanying electrocardiogram, were digitized with an arbitrary linear 252-step brightness scale with maximum and minimum brightness set to 252 and 0, respectively. Two end-diastoles immediately before and end-diastoles 2. 4. 10. and 12 immediately after the first appearance of intramyocardial contrast were selected for analysis for each injection. Each echocardiographic cross section was divided into 12 circumferential segments with the use of the posterior right ventriculoseptal junction as a landmark (figure 2). In each segment, a free-form crescent-shaped region was drawn that circumscribed the myocardial region of interest but carefully excluded specular endocardial and epicardial echocardiographic signals. At least six regions were drawn for each study and each included at least two segments on either side of the ensuing contrast defect. To assess the effect of contrast injection on the strength of echocardiographic signals returning from deeper myocardial structures, a background figure, 10 pixels deep and three segments wide and centered on the posterior pericardium, was also drawn. The mean pixel intensity encompassed in each of the above areas was calculated with a computer algorithm. The regions defined for the first preinjection end diastolic frame were transferred to the second and successive frames and intensity values were similarly calculated.
To determine the change in intensity resulting from contrast injection, the background intensity (mean of frames 1 and 2) for each segment was subtracted from the intensity value of each postinjection frame. Despite our use of the color videodensitometer to normalize preinjection baseline intensity settings, when all 35 studies are considered, the mean background intensity for any individual segment varied widely (from 6 to 210 units). Therefore, to express intensity changes in comparable units between segments with varying backgrounds, all values were expressed as a percentage of the gray-scale steps remaining after background subtraction. The mean of the intensity change seen in the four postinjection frames for each segment was defined as the contrast intensity change for that segment. showed progressively increasing levels of contrast enhancement after subsequent injections. Figure 3 shows a series of echocardiographic still frames recorded during the fourth, sixth, twelfth, and twentieth postinjection diastoles for the 1, 20, and 120 min observations in one of these animals. At 1 min, no delayed enhancement was seen inside the immediate contrast defect. After the 20 min injection, delayed (+1) enhancement occurred that was maximal by the twentieth postinjection diastole. After the 120 min injection, delayed (2 +) enhancement was maximal and was similar in intensity to the immediate level by the twelfth diastolic image. The radial contrast enhancement and radial microsphere flow maps for this animal are presented in figure 4 , top.
In the other seven animals, delayed contrast enhancement on later studies was seen in one CONTRAST GRADE CHANGE FIGURE 6 . Relationship of the change in qualitative contrast grade to the change in normalized microsphere-determined blood flow in the central ischemic region between any two successive observations. The regression line is solid.
Reimer et al. 12 and Koyanagi et al. 13 have shown, using the radioactive microsphere technique, that myocardial survival is prolonged in ischemic regions that receive more than 30% of normal blood flow. Our data indicate that contrast echocardiography can detect flows in this range in the ischemic region and suggest that, if fully developed and proven safe, this method could potentially assist in the selection of patients with large amounts of jeopardized yet viable myocardium who are likely to benefit from aggressive interventional approaches. At present, myocardial contrast echocardiography requires the supraaortic or intracoronary injection of microbubble-containing contrast agents. Although the exact methods used in the present study are not yet applicable to the clinical situation, there have been several recent encouraging preliminary reports. Leftsided injections of microbubble-containing agitated saline,'4 carbon dioxide solution,`5 and polygellin colloid'6 have been performed safely in small numbers of patients in the catheterization laboratory. Our study was performed with a pigtail catheter that was modified by introducing a 90 degree bend just above the first catheter side holes and therefore was easily advanced to the level of the aortic root solely by the use of echocardiographic guidance. This experience suggests that aortic root injection of echocardiographic contrast may be possible in a monitored situation outside the catheterization laboratory, such as in the coronary care unit.
No agent such as hydrogen peroxide and blood solution that is capable of producing intense myocardial contrast by supra-aortic injection has as yet been proven safe for use in man. Studies have been reported by Gaffney et al.'7 and Wang et al. ' 8 of the safe use of doses of hydrogen peroxide similar to ours for rightsided injections in over 100 patients. Our experience with an animal preparation4' 5shows only occasional transient and relatively minor alterations in hemodynamics, and is similar to that reported by Gaffney,`" who observed no changes in hemodynamics or alertness and no sign of distress in five conscious dogs receiving 10 ml bolus injections of 0.2% solution into the left atrium. Recent preliminary reports by Levine et al. '9 and Holt et al. 20 indicate that transient decreases in contractility can be observed after the intracoronary injection of contrast agents such as meglumine/saline, Fluosol DA, 50% dextrose, and hydrogen peroxide solution. The degree of the subjectively assessed decrease in contraction seen in Levine's study appeared to be proportional to the amount of contrast enhancement.'9 The amount of regional contractile depression measured by ultrasonic crystals by Holt20 was too small and transient to affect ventricular dP/dt. The occurrence of these contractile changes does suggest that at least some transient microcirculatory blockage may occur as a result of the contrast bubbles. Further studies will be necessary to determine whether these transient changes result in any long-term deleterious consequences.
The contrast agent used in this study was a mixture of dilute hydrogen peroxide solution and autologous blood, which results in the generation of heterogeneous oxygen microbubbles ranging from 10 to 100 gm in diameter (mean 52 ,m). '°Although a constant volume of this solution was injected by a standardized approach, there was undoubtedly some variability in the number and size of the microbubbles delivered to the coronary circulation. With our agent, the mean increase in intensity reached in normal segments averaged 61 ± 20% of the available gray scale with 23 of 111 segment pairs varying by more than 20% on two successive injections. No injection sequences were excluded in our study for inadequate or overabundant contrast enhancement because these criteria had not been established; however, close attention to values in normal areas, both in terms of adequacy of enhancement and study-to-study reproducibility, might be expected to improve the predictive value of changes in contrast enhancement for changes in myocardial flow within the ischemic region. The exact relationship between microbubble size, number, and time/gain compensation has not yet been defined, but the relationship between bubble distribution and echo intensity is likely to be closest for homogeneously sized bubbles. Inves One key variable affecting quantitative analysis that was not completely appreciated at the time the studies were performed is the effect of preinjection region intensity on analyses of the amount of change in that intensity. High regional intensities before injection limit the available dynamic range for display of contrast enhancement. In addition, there is a modest decrease in echo intensity for deeper target levels during the course of contrast injection that occurs as a result of interference induced by the presence of contrast material at levels closer to the transducer. With very high baseline intensities, this attenuation may be quantitatively similar to the increase in echo signal strength that occurs in a region as a result of contrast appearance. In our study, the two points farthest from the regression line for the quantitative analysis (4, 39 and 9, 52; figure 5) occurred in the same animal. Although a color videodensitometer was used interactively before the initial injection in each study in an attempt to achieve a homogeneous low baseline level of regional pixel intensity, the baseline intensity in the ischemic region was 
